A national subject matter expert on chronic pain. Triple board-certified in Pain Medicine, Addiction Medicine, and Anesthesiology. Serves as a member of the FDA’s Analgesic and Anesthetic Drug Products Advisory Committee and was a member of the Joint Commission Standards Review Panel for Pain Assessment and Management, as well as the Joint Commission’s Technical Advisory Panel for Pain Assessment and Management in Behavioral Healthcare. Past-President of the Texas Society of Addiction Medicine and a member of the American Society of Addiction Medicine’s Drug Testing Expert Panel. Serves as a member of ASAM’s Practice Management and Regulatory Affairs Committee and the Pain and Addiction Educational Program Planning Committee, as well as a member of the ASRA/ASA working group on Substance Use Disorders, which is creating the foundational guidance for pain doctors and anesthesiologists throughout the country by defining the educational needs and skill sets necessary for pain doctors and anesthesiologists to effectively identify and manage complex pain patients and substance use disorders.